Home » Topics » BioWorld Science

BioWorld Science
RSS

Myloral development update

March 15, 1996

Yamanouchi claims PCP antagonist for dementia

March 15, 1996

BB-3644 in development for multiple sclerosis

March 15, 1996

Lexipafant evaluated for MS treatment

March 15, 1996

Sparta acquires Lexin

March 15, 1996

Yissum claims novel anticonvulsants

March 15, 1996

Elan, Athena to merge

March 15, 1996

BASF to acquire majority stake in Hokuriku

March 15, 1996

Bayer acquires rights to CryoLife technology

March 15, 1996

CIMA signs agreements for OraSolv drug delivery technology

March 15, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...